Nanomedicine Strategies Utilizing Lipid-Based Nanoparticles for Liver Cancer Therapy: Exploring Signaling Pathways and Therapeutic Modalities

Nanomedicine Strategies Utilizing Lipid-Based Nanoparticles for Liver Cancer Therapy: Exploring Signaling Pathways and Therapeutic Modalities

Liver cancer, specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related deaths, following pancreatic cancer. The 5-year overall survival rate for HCC remains relatively low. Currently, there are multiple treatment options available for HCC, including systemic drugs,...

Full description

Saved in:
Bibliographic Details
Main Authors: Fereshteh Asgharzadeh, Maryam Moradi Binabaj, Sahar Fanoudi, William C. Cho, Yu-jeong Yang, Maryam Azarian, Mehdi Shafiee Ardestani, Nasim Nasiri, Marzieh Ramezani Farani, Yun Suk Huh
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2024-10-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
liver cancer
hepatocellular carcinoma
signaling pathways
therapeutic approaches
lipid-based nanoparticles
nanomedicine
Online Access:https://apb.tbzmed.ac.ir/PDF/apb-14-513.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://apb.tbzmed.ac.ir/PDF/apb-14-513.pdf

Similar Items